Related Experiment Video
Updated: Aug 22, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Urinary excretion of calcium and phosphate in preterm infants
Narendra Aladangady1, Pietro G Coen, Madeleine P White
1Department of Neonatology, The Queen Mother's Hospital, Glasgow, UK. N.Aladangady@qmw.ac.uk
Insights
This study establishes reference ranges for urinary calcium (UCa/Cr) and phosphate (UPO(4)/Cr) creatinine ratios in preterm infants. Factors like postnatal age and certain medications influence these crucial metabolic bone indicators.
Area of Science:
- Neonatal Medicine
- Pediatric Nephrology
- Clinical Chemistry
Background:
- Preterm infants are at risk for metabolic bone disease.
- Establishing reference ranges for urinary calcium (UCa/Cr) and phosphate (UPO(4)/Cr) creatinine ratios is essential for monitoring bone health.
- Current nutritional guidelines aim to support bone development in this vulnerable population.
Purpose of the Study:
- To determine reference ranges for UCa/Cr and UPO(4)/Cr ratios in preterm infants.
- To investigate factors influencing these urinary ratios, including gestational age, nutritional intake, and medication use.
- To provide data for optimizing metabolic bone screening and management in preterm neonates.
Main Methods:
- Spot urine samples were collected from 186 preterm infants (24-34 weeks gestation) bi-weekly from 3 to 18 weeks of life.
- UCa/Cr and UPO(4)/Cr ratios were measured as part of routine metabolic bone screening.
- Data on infant characteristics, nutrition, plasma biochemistry, and drug use (furosemide, dexamethasone, theophylline) were collected.
Main Results:
- The 95th percentile for UCa/Cr decreased significantly with postnatal age, while UPO(4)/Cr showed no significant age-related change.
- Small for gestational age (SGA) infants had lower UCa/Cr, and infants on total parenteral nutrition (TPN) had higher UCa/Cr and lower UPO(4)/Cr.
- Furosemide and theophylline use were associated with increased UCa/Cr ratios.
Conclusions:
- Reference ranges for UCa/Cr and UPO(4)/Cr in preterm infants were established.
- Postnatal age, SGA status, TPN, and specific medications (furosemide, theophylline) significantly influence these ratios.
- These findings aid in the interpretation of metabolic bone screening in preterm infants.
Abstract:
The aims of this study were to determine reference ranges for the urinary calcium (UCa/Cr) and phosphate (UPO(4)/Cr) creatinine ratios and to study factors influencing these ratios in a representative population of preterm infants managed according to current nutritional guidelines. Spot urine samples were obtained from 186 preterm infants (gestation 24-34 weeks) for measurement of UCa/Cr and UPO(4)/Cr ratios as part of a routine metabolic bone screening program, once every 2-4 weeks from the 3rd to the 18th week of life. Data were also collected on gender, appropriate or small for gestational age (SGA), nutrition [total parenteral nutrition (TPN), preterm or term formula, and breast milk], plasma Ca, P0(4), urea, and electrolytes and on the use of drugs (frusemide, dexamethasone, and theophylline). Data from infants treated with any of these three drugs were analyzed separately and not included in establishing the reference ranges for UCa/Cr and UPO(4)/Cr. The mean gestational age of the study population was 28 weeks (range 24-34 weeks). The 95th percentile for UCa/Cr at 3 weeks of age was 3.8 mmol/mmol and decreased significantly with increasing postnatal age (P<0.001). The 95th per-centile for UPO(4)/Cr was 26.69 mmol/mmol at 3 weeks of age, but this did not change significantly with increasing postnatal age (P=0.296). On univariate analysis there was no significant association of UCa/Cr and UPO(4)/Cr with gender and type of enteral nutrition. The UCa/Cr was lower in infants who were SGA (P=0.013) and with low plasma Ca (P=0.008). Infants on TPN had significantly higher UCa/Cr (P =0.019) and lower UPO(4)/Cr ratios(P<0.001). Multivariate analysis confirmed the decrease in UCa/Cr ratio with increasing postnatal age, but the SGA effect was eliminated. The use of furosemide(P<0.001) and theophylline (P=0.003) was associated with a significant increase in the UCa/Cr ratio. The use of dexamethasone was also associated with an increase in UCa/Cr ratio, but this did not achieve statistical significance (P=0.339). The use of furosemide, theophylline,and dexamethasone had no effect on UPO(4)/Cr. We report a reference range for UCa/Cr and UPO(4)/Cr ratios and factors influencing these ratios in a representative population of preterm infants between 24 and 34 weeks gestation, managed according to current nutritional guide-lines.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Skeleton and Calcium Homeostasis
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Calculi I: Introduction
Introduction to Electrolytes
Role of Sodium
One...
